Based on the analysis of LeMaitre Vascular's profitability, liquidity, and operating efficiency, LeMaitre Vascular is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April. At this time, LeMaitre Vascular's Other Stockholder Equity is comparatively stable compared to the past year. Total Liabilities is likely to gain to about 225.3 M in 2025, whereas Other Current Assets are likely to drop slightly above 4.6 M in 2025. Key indicators impacting LeMaitre Vascular's financial strength include:
The financial analysis of LeMaitre Vascular is a critical element in measuring its lifeblood. Investors should not minimize LeMaitre Vascular's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Please note, the imprecision that can be found in LeMaitre Vascular's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of LeMaitre Vascular. Check LeMaitre Vascular's Beneish M Score to see the likelihood of LeMaitre Vascular's management manipulating its earnings.
LeMaitre Vascular Stock Summary
LeMaitre Vascular competes with InfuSystems Holdings, Pro Dex, Utah Medical, Milestone Scientific, and Hologic. LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. Lemaitre Vascular operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 450 people.
The reason investors look at the income statement is to determine what LeMaitre Vascular's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining LeMaitre Vascular's current stock value. Our valuation model uses many indicators to compare LeMaitre Vascular value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LeMaitre Vascular competition to find correlations between indicators driving LeMaitre Vascular's intrinsic value. More Info.
LeMaitre Vascular is rated fifth overall in return on equity category among its peers. It is rated fourth overall in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for LeMaitre Vascular is roughly 1.91 . At this time, LeMaitre Vascular's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value LeMaitre Vascular by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
LeMaitre Vascular Systematic Risk
LeMaitre Vascular's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. LeMaitre Vascular volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on LeMaitre Vascular correlated with the market. If Beta is less than 0 LeMaitre Vascular generally moves in the opposite direction as compared to the market. If LeMaitre Vascular Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one LeMaitre Vascular is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of LeMaitre Vascular is generally in the same direction as the market. If Beta > 1 LeMaitre Vascular moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in LeMaitre Vascular Stock are looking for potential investment opportunities by analyzing not only static indicators but also various LeMaitre Vascular's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of LeMaitre Vascular growth as a starting point in their analysis.
LeMaitre Vascular March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of LeMaitre Vascular help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of LeMaitre Vascular. We use our internally-developed statistical techniques to arrive at the intrinsic value of LeMaitre Vascular based on widely used predictive technical indicators. In general, we focus on analyzing LeMaitre Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build LeMaitre Vascular's daily price indicators and compare them against related drivers.
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.